Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates

Therapeutic Drug Monitoring

Volumn 28, Issue 2, 2006, Pages 226-231

  Pullen, Joyce ^a   Stolk, Leo M L ^a   Nieman, Fred H M ^a   Degraeuwe, Pieter L J ^a   Van Tiel, Frank H ^a   Zimmermann, Luc J I ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Amoxicillin; Dosage regimen; Neonates; Population pharmacokinetics

Indexed keywords

AMOXICILLIN; GENTAMICIN;

ARTICLE; BODY WEIGHT; CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE REGRESSION; NEWBORN; PREMATURITY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPSIS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BODY WEIGHT; DATA INTERPRETATION, STATISTICAL; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; GENTAMICINS; HALF-LIFE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; PREMATURE BIRTH; REGRESSION ANALYSIS;

EID: 33748188884     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000198648.39751.11     Document Type: Article

References (21)

1. Fanos V, Dall'Agnola A. Antibiotics in neonatal infections: a review. Drugs. 1999;58:405-427.
2. Charles BG, Preechagoon Y, Lee TC, et al. Population pharmacokinetics of intravenous amoxicillin in very low birth weight infants. J Pharm Sci. 1997;86:1288-1292.
3. Huisman-de Boer JJ, Anker van den JN, Vogel M, et al. Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks. Antimicrob Agents Chemother. 1995;39:431-434.
4. Autret E, Laugier J, Marimbu J, et al. Comparaison des concentrations plasmatiques d'amoxicilline par voie orale et intraveineuse dans les colonisations bactériennes néonatales. Arch Fr Pediatr. 1988;45:679-682.
5. Peskine F, Despaux E, Rodiere M, et al. Étude pharmacociné tique et clinique de l'amoxicilline intra-veineuse chez le nouveau-né. Pathol Biol (Paris). 1982;30:476-480.
6. Shaffer CL, Davey AM, Ransom JL, et al. Ampicillin-induced neurotoxicity in very-low-birth-weight neonates. Ann Pharmacother. 1998;32:482-484.
7. Saez-Llorens X, McCracken GH. Clinical pharmacology of antibacterial agents. In: Remington JS, Klein JO, eds. Infectious Disease of the Fetus, Newborn and Infants. Philadelphia: Saunders; 1995:1287-1336.
8. Baltimore RS. Neonatal sepsis: epidemiology and management. Paediatr Drugs. 2003;5:723-740.
9. Jones DP, Gaber L, Nilsson GR, et al. Acute renal failure following amoxicillin overdose. Clin Pediatr (Phila). 1993;32:735-739.
10. Hoog de M, Mouton JW, Anker van den JN. New dosing strategies for antibacterial agents in the neonate. Semin Fetal Neonatal Med. 2005;10:185-194.
11. Wertz AW, Heeren MM. Delivery room resuscitation. In: Pomerance JJ, Richardson CJ, eds. Neonatology for the Clinician. Norwalk, CT: Appleton & Lange; 1993:93-121.
12. Stolk LML, Degraeuwe PLJ, Nieman FHM, et al. Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates. Ther Drug Monit. 2002;24:527-531.
13. Hey E, Hall C. Neonatal Formulary. 4th ed. London: Blackwell BMJ Books; 2003.
14. Fowlie PW, Davis PG. Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F464-F466.
15. Dodge WF, Jelliffe RW, Zwischenberger JB, et al. Population pharmacokinetic models: effect of explicit versus assumed constant serum concentration assay error patterns upon parameter values of gentamicin in infants on and off extracorporeal membrane oxygenation. Ther Drug Monit. 1994;16:552-559.
16. Proost JH, Meijer DKF. MWPHARM, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med. 1992;22:155-163.
17. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Standard M100-S12. Wayne, Pa: NCCLS; 2002.
18. Koren G, James A, Perlman M. A simple method for the estimation of glomerular filtration rate by gentamicin pharmacokinetics during routine drug monitoring in the newborn. Clin Pharmacol Ther. 1985;38:680-685.
19. Morselli PL. Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet. 1989;17(Suppl 1):13-28.
20. Guignard JP, Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics. 1999;103:e49.
21. Kaplan JM, McCracken GH, Horton LJ, et al. Pharmacologic studies in neonates given large dosages of ampicillin. J Pediatr. 1974;84:571-577.